Radial artery or saphenous vein for coronary artery bypass grafting
Radial artery or saphenous vein for coronary artery bypass grafting
复制标题
DOI：
10.1016/j.tcm.2021.09.007
复制
发表时间：
2022-11-21
影响因子：
9.3
通讯作者：
Gaudino, Mario
中科院分区：
文献类型：
--
作者：
Audisio, Katia;Halbreiner, M. Scott;Gaudino, Mario
冠状动脉疾病（CAD）是世界上最常见的心血管疾病，影响了1800多万美国成年人。冠状动脉旁路移植术（CABG）是左主干或三支血管冠心病患者的标准治疗方法。从历史上看，隐静脉（SV）已被用于CABG患者的大多数冠状动脉旁路，但最近的数据表明，使用桡动脉（RA）而不是SV，可改善心脏预后和提高生存率。这篇综述的目的是总结目前关于在多血管CAD患者中使用RA和SV进行冠脉搭桥的文献。(c) 2021爱思唯尔公司版权所有。
Coronary artery disease (CAD) is the most common cardiovascular disease worldwide, affecting over 18 million American adults. Coronary artery bypass grafting (CABG) is the standard of care for patients with left main or triple vessel CAD. Historically, the saphenous vein (SV) has been utilized to bypass the majority of the coronary vessels in patients undergoing CABG, but more recent data suggest that the use of the radial artery (RA), rather than the SV, is associated with improved cardiac outcomes and better survival. The aim of this review is to summarize the current literature on the use of RA and SV for CABG in patients with multivessel CAD. (c) 2021 Elsevier Inc. All rights reserved.